Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,423 | 195 | 99.6% |
| Education | $14.48 | 1 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $689.75 | 42 | $0 (2021) |
| Janssen Pharmaceuticals, Inc | $475.92 | 35 | $0 (2022) |
| Merck Sharp & Dohme Corporation | $320.90 | 5 | $0 (2019) |
| Novo Nordisk Inc | $240.96 | 15 | $0 (2023) |
| Amgen Inc. | $202.51 | 13 | $0 (2021) |
| ABBVIE INC. | $177.25 | 12 | $0 (2023) |
| GlaxoSmithKline, LLC. | $147.96 | 2 | $0 (2019) |
| Amarin Pharma Inc. | $138.11 | 8 | $0 (2022) |
| PFIZER INC. | $137.92 | 10 | $0 (2021) |
| Lilly USA, LLC | $125.15 | 5 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $105.29 | 6 | ABBVIE INC. ($33.18) |
| 2022 | $357.24 | 20 | Novo Nordisk Inc ($80.94) |
| 2021 | $917.68 | 61 | AstraZeneca Pharmaceuticals LP ($204.81) |
| 2020 | $692.05 | 48 | AstraZeneca Pharmaceuticals LP ($201.61) |
| 2019 | $741.45 | 47 | AstraZeneca Pharmaceuticals LP ($155.69) |
| 2018 | $168.68 | 6 | Merck Sharp & Dohme Corporation ($93.41) |
| 2017 | $455.06 | 8 | Merck Sharp & Dohme Corporation ($204.88) |
All Payment Transactions
196 individual payment records from CMS Open Payments — Page 3 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/29/2021 | Novo Nordisk Inc | RYBELSUS (Drug) | Food and Beverage | In-kind items and services | $12.76 | General |
| Category: Diabetes | ||||||
| 06/29/2021 | Novo Nordisk Inc | RYBELSUS (Drug) | Food and Beverage | In-kind items and services | $11.40 | General |
| Category: Diabetes | ||||||
| 06/17/2021 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $14.81 | General |
| Category: NEUROSCIENCE | ||||||
| 06/15/2021 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $19.63 | General |
| Category: Cardiovascular | ||||||
| 06/11/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $16.38 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/08/2021 | Amgen Inc. | Aimovig (Biological), Otezla, Repatha | Food and Beverage | In-kind items and services | $13.62 | General |
| Category: Neuroscience | ||||||
| 06/04/2021 | SANOFI-AVENTIS U.S. LLC | SOLIQUA 100/33 (Biological) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 05/19/2021 | PFIZER INC. | PREVNAR 13 (Biological) | Food and Beverage | In-kind items and services | $14.03 | General |
| Category: VACCINES | ||||||
| 05/18/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $14.03 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/17/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.15 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/14/2021 | PFIZER INC. | ELIQUIS (Drug), COLOGUARD DNA CAPTURE REAGENTS | Food and Beverage | In-kind items and services | $14.24 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 05/11/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $12.75 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/10/2021 | Novo Nordisk Inc | RYBELSUS (Drug) | Food and Beverage | In-kind items and services | $19.81 | General |
| Category: Diabetes | ||||||
| 04/28/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $11.05 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/21/2021 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $14.59 | General |
| Category: NEUROSCIENCE | ||||||
| 04/14/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $14.09 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/09/2021 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.09 | General |
| Category: Diabetes | ||||||
| 04/08/2021 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $13.67 | General |
| Category: Cardiovascular | ||||||
| 03/26/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $15.78 | General |
| Category: NEUROSCIENCE | ||||||
| 03/24/2021 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.83 | General |
| Category: Diabetes | ||||||
| 03/17/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPIRIVA RESPIMAT (Drug) | Food and Beverage | In-kind items and services | $14.72 | General |
| Category: RESPIRATORY | ||||||
| 03/11/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $19.36 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/10/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $14.90 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/10/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $12.90 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/02/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $12.75 | General |
| Category: Cardiovascular and Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 179 | 215 | $23,816 | $7,184 |
| 2022 | 14 | 652 | 827 | $94,110 | $42,601 |
| 2021 | 31 | 2,852 | 4,003 | $387,586 | $102,726 |
| 2020 | 38 | 2,943 | 3,982 | $374,987 | $91,707 |
All Medicare Procedures & Services
87 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 50 | 54 | $11,718 | $3,020 | 25.8% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 24 | 54 | $3,780 | $1,872 | 49.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 44 | 46 | $7,038 | $1,779 | 25.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 61 | 61 | $1,280 | $512.40 | 40.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 132 | 155 | $33,635 | $14,024 | 41.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 166 | 194 | $29,682 | $12,863 | 43.3% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 41 | 126 | $8,820 | $5,828 | 66.1% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 47 | 47 | $5,546 | $3,221 | 58.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 13 | 13 | $2,535 | $1,626 | 64.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 55 | 55 | $2,255 | $1,512 | 67.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 11 | 11 | $3,025 | $1,305 | 43.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 15 | 15 | $2,700 | $918.02 | 34.0% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2022 | 13 | 13 | $689.00 | $450.78 | 65.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 104 | 114 | $2,392 | $335.64 | 14.0% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2022 | 13 | 17 | $1,190 | $276.06 | 23.2% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 17 | 19 | $437.00 | $195.34 | 44.7% |
| 81003 | Automated urinalysis test | Office | 2022 | 13 | 14 | $490.00 | $30.92 | 6.3% |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | Office | 2022 | 12 | 34 | $714.00 | $15.07 | 2.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 289 | 500 | $101,000 | $40,254 | 39.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 252 | 318 | $44,520 | $18,244 | 41.0% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 70 | 70 | $21,700 | $7,486 | 34.5% |
| 90694 | Influenza virus vaccine, quadrivalent (aiiv4), inactivated, adjuvanted, preservative free, for injection into muscle, 0.5 ml dosage | Office | 2021 | 87 | 87 | $12,180 | $5,779 | 47.5% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2021 | 271 | 389 | $32,093 | $5,189 | 16.2% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2021 | 278 | 397 | $65,505 | $4,182 | 6.4% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2021 | 196 | 241 | $26,510 | $4,049 | 15.3% |
About Dr. Sheree Nwanegwo, M.D
Dr. Sheree Nwanegwo, M.D is a Family Medicine healthcare provider based in Myrtle Beach, South Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/21/2006. The National Provider Identifier (NPI) number assigned to this provider is 1487610382.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sheree Nwanegwo, M.D has received a total of $3,437 in payments from pharmaceutical and medical device companies, with $105.29 received in 2023. These payments were reported across 196 transactions from 30 companies. The most common payment nature is "Food and Beverage" ($3,423).
As a Medicare-enrolled provider, Nwanegwo has provided services to 6,626 Medicare beneficiaries, totaling 9,027 services with total Medicare billing of $244,217. Data is available for 4 years (2020–2023), covering 87 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Myrtle Beach, SC
- Active Since 04/21/2006
- Last Updated 11/16/2020
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1487610382
Products in Payments
- XARELTO (Drug) $439.10
- FARXIGA (Drug) $379.91
- JANUMET (Drug) $213.38
- SYMBICORT (Drug) $145.60
- Vascepa (Drug) $138.11
- BEVESPI AEROSPHERE (Drug) $125.00
- JARDIANCE (Drug) $114.97
- JANUVIA (Drug) $107.52
- EVENITY (Biological) $102.79
- Aimovig (Biological) $99.72
- Tymlos (Biological) $92.74
- SOLIQUA 100/33 (Biological) $89.03
- INCRUSE (Drug) $80.59
- RYBELSUS (Drug) $79.68
- TRINTELLIX (Drug) $77.40
- Ozempic (Drug) $77.10
- VRAYLAR (Drug) $71.52
- TRELEGY ELLIPTA (Drug) $67.37
- UBRELVY (Drug) $54.44
- Tresiba (Drug) $51.62
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Myrtle Beach
Dr. John Karl, Md, MD
Family Medicine — Payments: $15,740
Chad Huberty, M.d, M.D
Family Medicine — Payments: $13,773
Jeffrey Lindaberry, D.o, D.O
Family Medicine — Payments: $12,797
Dr. William Gammon, Md, MD
Family Medicine — Payments: $10,783
Dr. Kristen Carr, M.d, M.D
Family Medicine — Payments: $10,590
William Prenatt, Md, MD
Family Medicine — Payments: $10,533